SERIAL MONITORING OF LEFT VENTRICULAR EJECTION FRACTION IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES RECEIVING ANTHRACYCLINE-BASED CHEMOTHERAPY

被引:1
|
作者
Demetriades, Polyvios [1 ]
Ho, Emily [1 ]
机构
[1] Sandwell & West Birmingham NHS Hosp Trust, Birmingham, W Midlands, England
关键词
D O I
10.1136/heartjnl-2016-309890.127
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
127
引用
收藏
页码:A89 / A90
页数:4
相关论文
共 50 条
  • [21] Relation of Pre-anthracycline Serum Bilirubin Levels to Left Ventricular Ejection Fraction After Chemotherapy
    Vera, Trinity
    D'Agostino, Ralph B., Jr.
    Jordan, Jennifer H.
    Whitlock, Matthew C.
    Melendez, Giselle C.
    Lamar, Zanetta S.
    Porosnicu, Mercedes
    Bonkovsky, Herbert L.
    Poole, Leslie B.
    Hundley, W. Gregory
    AMERICAN JOURNAL OF CARDIOLOGY, 2015, 116 (11): : 1752 - 1755
  • [22] Susceptibility of patients receiving chemotherapy for haematological malignancies to scabies
    Hosoi, H.
    Nishikawa, S.
    Kida, Y.
    Kishi, T.
    Murata, S.
    Iwamoto, M.
    Toyoda, Y.
    Yamada, Y.
    Ikeda, T.
    Sonoki, T.
    JOURNAL OF HOSPITAL INFECTION, 2020, 106 (03) : 594 - 599
  • [23] Cardioprotective effect of Trimetazidine in patients with early breast cancer receiving anthracycline-based chemotherapy
    Delle Donne, M. G.
    Iannielli, A.
    Capozza, P.
    De Caterina, R.
    Marzilli, M.
    EUROPEAN HEART JOURNAL, 2020, 41 : 880 - 880
  • [24] Major Cardiac Events and the Value of Echocardiographic Evaluation in Patients Receiving Anthracycline-Based Chemotherapy
    Wang, Lin
    Tan, Timothy C.
    Halpern, Elkan F.
    Neilan, Tomas G.
    Francis, Sanjeev A.
    Picard, Michael H.
    Fei, Hongwen
    Hochberg, Ephraim P.
    Abramson, Jeremy S.
    Weyman, Arthur E.
    Kuter, Irene
    Scherrer-Crosbie, Marielle
    AMERICAN JOURNAL OF CARDIOLOGY, 2015, 116 (03): : 442 - 446
  • [25] ATHEROGENIC PLASMA INDEX LEVELS IN BREAST CANCER PATIENTS RECEIVING ANTHRACYCLINE-BASED CHEMOTHERAPY
    Gundogdu, Utku Donem
    Coban, Funda Karabag
    FRESENIUS ENVIRONMENTAL BULLETIN, 2022, 31 (01): : 787 - 791
  • [26] Artificial intelligence electrocardiogram as a novel screening tool to detect a newly abnormal left ventricular ejection fraction after anthracycline-based cancer therapy
    Jacobs, Johanna E. J.
    Greason, Grace
    Mangold, Kathryn E.
    Wildiers, Hans
    Willems, Rik
    Janssens, Stefan
    Noseworthy, Peter
    Lopez-Jimenez, Francisco
    Voigt, Jens-Uwe
    Friedman, Paul
    Van Aelst, Lucas
    Vandenberk, Bert
    Attia, Zachi Itzhak
    Herrmann, Joerg
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2023, : 560 - 566
  • [27] Left ventricular mass by cardiac magnetic resonance imaging and adverse cardiovascular outcomes in patients treated with anthracycline-based chemotherapy
    Tomas G Neilan
    Diego Pena-Herrera
    Otavio R Coelho-Filho
    Michael Jerosch-Herold
    Javid Moslehi
    Raymond Kwong
    Journal of Cardiovascular Magnetic Resonance, 14 (Suppl 1)
  • [28] Prediction of trastuzumab-induced cardiotoxicity in breast cancer patients receiving anthracycline-based chemotherapy
    Wafaa S. El-Sherbeny
    Nesreen M. Sabry
    Radwa M. Sharbay
    Journal of Echocardiography, 2019, 17 : 76 - 83
  • [29] THE UTILITY OF CARDIAC BIOMARKERS DURING ANTHRACYCLINE CHEMOTHERAPY FOR THE DETECTION OF CARDIAC EVENTS: COMPARISON LEFT VENTRICULAR EJECTION FRACTION
    Stevens, Patrick
    Freehardt, Darla
    Estis, Joel
    Todd, John
    Fisch, Michael
    Lenihan, Daniel
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) : A790 - A790
  • [30] Fragmented QRS formation and its predictors in patients with breast cancer receiving anthracycline-based chemotherapy
    Dural, Muhammet
    Demir, Lutfiye
    Babayigit, Erdi
    Junushova, Bermet
    Mert, Kadir Ugur
    Ulus, Taner
    Cavusoglu, Yuksel
    Yildiz, Bulent
    Dincer, Murat
    Gorenek, Bulent
    JOURNAL OF ELECTROCARDIOLOGY, 2019, 54 : 5 - 9